These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 18508633)

  • 41. Pattern of trisomy 1q in hematological malignancies: a single institution experience.
    Djordjević V; Dencić-Fekete M; Jovanović J; Drakulić D; Stevanović M; Janković G; Gotić M
    Cancer Genet Cytogenet; 2008 Oct; 186(1):12-8. PubMed ID: 18786437
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Transcription regulators altered in hematologic malignancy.
    Yunis JJ; Thompson JD
    Nouv Rev Fr Hematol (1978); 1991; 33(2):92-6. PubMed ID: 1766862
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Chromosomal abnormalities in hematologic malignant diseases.
    Le Beau MM
    Prog Clin Biol Res; 1990; 340B():325-35. PubMed ID: 2203012
    [No Abstract]   [Full Text] [Related]  

  • 44. Cytogenetics in acute leukemia.
    Mrózek K; Heerema NA; Bloomfield CD
    Blood Rev; 2004 Jun; 18(2):115-36. PubMed ID: 15010150
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cytogenetic and clinical investigations in 76 cases with therapy-related leukemia and myelodysplastic syndrome.
    Iurlo A; Mecucci C; Van Orshoven A; Michaux JL; Boogaerts M; Noens L; Bosly A; Louwagie A; Van Den Berghe H
    Cancer Genet Cytogenet; 1989 Dec; 43(2):227-41. PubMed ID: 2598167
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Specific chromosomal changes (aberrations)--supplementary marker of malignant degeneration in oncomorphologic studies].
    Anichkov NM; Mamaev NN; Mamaeva SE; Skripnik SV
    Arkh Patol; 1986; 48(6):87-91. PubMed ID: 3530204
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Rearrangements of 11q in patients with hematologic malignancies].
    Brezinová J; Zemanová Z; Kurková S; Sindelárová L; Sisková M; Cermák J; Michalová K
    Cas Lek Cesk; 2002 Sep; 141 Suppl():38-40. PubMed ID: 12428421
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Recurrent Cytogenetic Abnormalities in Myelodysplastic Syndromes.
    Wall M
    Methods Mol Biol; 2017; 1541():209-222. PubMed ID: 27910026
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Distribution of cytogenetic abnormalities in myelodysplastic syndromes, Philadelphia negative myeloproliferative neoplasms, and the overlap MDS/MPN category.
    Bacher U; Schnittger S; Kern W; Weiss T; Haferlach T; Haferlach C
    Ann Hematol; 2009 Dec; 88(12):1207-13. PubMed ID: 19415278
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cytogenetic correlation with disease status and treatment outcome in advanced stage leukemia post bone marrow transplantation: a Southwest Oncology Group study (SWOG-8612).
    Slovak ML; Kopecky KJ; Wolman SR; Henslee-Downey JP; Appelbaum FR; Forman SJ; Blume KG
    Leuk Res; 1995 Jun; 19(6):381-8. PubMed ID: 7596150
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Multiplex fluorescence in situ hybridization in identifying chromosome involvement of complex karyotypes in de novo myelodysplastic syndromes and acute myeloid leukemia.
    Xu W; Li JY; Liu Q; Zhu Y; Pan JL; Qiu HR; Xue YQ
    Int J Lab Hematol; 2010 Feb; 32(1 Pt 1):e86-95. PubMed ID: 20089000
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Chromosome abnormalities in human cancer and leukemia.
    Sandberg AA
    Mutat Res; 1991 Apr; 247(2):231-40. PubMed ID: 2011141
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Association of loss of heterozygosity with cytogenetic abnormalities in acute myeloid leukemia and myelodysplastic syndrome.
    Pinheiro RF; Serio FM; Silva MR; Briones MR; Chauffaille ML
    Braz J Med Biol Res; 2008 Jul; 41(7):610-4. PubMed ID: 18719743
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Chromosome abnormalities in early cancers].
    Maeda S; Horio M; Kitazawa S; Sugiyama T
    Gan No Rinsho; 1988 Aug; 34(10):1264-72. PubMed ID: 3172486
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Applications of Fluorescence In Situ Hybridization Technology in Malignancies.
    Tansatit M
    Methods Mol Biol; 2017; 1541():75-90. PubMed ID: 27910016
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Two cases assessed for myeloid disorders had an unexpected twist.
    Reddy KS
    Cancer Genet Cytogenet; 2008 Mar; 181(2):138-40. PubMed ID: 18295667
    [No Abstract]   [Full Text] [Related]  

  • 57. Molecular Cytogenetic Approach to Characterize Novel and Cryptic Chromosome Abnormalities in Childhood Myeloid Malignances of Fanconi Anemia.
    Borges ML; Capela de Matos RR; Amaral BD; Soares-Ventura EM; Leite EP; Silva MO; Cornélio MT; Silva ML; Liehr T; Marques-Salles TD
    J Pediatr Hematol Oncol; 2017 Mar; 39(2):e85-e91. PubMed ID: 28212262
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cytogenetic changes in the progression of lymphoma.
    Knutsen T
    Leuk Lymphoma; 1998 Sep; 31(1-2):1-19. PubMed ID: 9720711
    [TBL] [Abstract][Full Text] [Related]  

  • 59. BCL11B rearrangements probably target T-cell neoplasia rather than acute myelocytic leukemia.
    MacLeod RA; Nagel S; Drexler HG
    Cancer Genet Cytogenet; 2004 Aug; 153(1):88-9. PubMed ID: 15325104
    [No Abstract]   [Full Text] [Related]  

  • 60. Detection of an Abnormal Myeloid Clone by Flow Cytometry in Familial Platelet Disorder With Propensity to Myeloid Malignancy.
    Ok CY; Leventaki V; Wang SA; Dinardo C; Medeiros LJ; Konoplev S
    Am J Clin Pathol; 2016 Feb; 145(2):271-6. PubMed ID: 26800764
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.